DEFB105A

gene
On this page

Also known as DEFB-5

Summary

DEFB105A (defensin beta 105A, HGNC:18087) is a protein-coding gene on chromosome 8p23.1, encoding Beta-defensin 105 (Q8NG35). Has antibacterial activity.

Defensins form a family of antimicrobial and cytotoxic peptides made by neutrophils. Defensins are short, processed peptide molecules that are classified by structure into three groups: alpha-defensins, beta-defensins and theta-defensins. All beta-defensin genes are densely clustered in four to five syntenic chromosomal regions. Chromosome 8p23 contains at least two copies of the duplicated beta-defensin cluster. This duplication results in two identical copies of defensin, beta 105, DEFB105A and DEFB105B, in tail-to-tail orientation. This gene, DEFB105A, represents the more centromeric copy.

Source: NCBI Gene 245908 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 8 total
  • MANE Select transcript: NM_152250

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:18087
Approved symbolDEFB105A
Namedefensin beta 105A
Location8p23.1
Locus typegene with protein product
StatusApproved
AliasesDEFB-5
Ensembl geneENSG00000186562
Ensembl biotypeprotein_coding
Entrez245908

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 protein_coding

ENST00000334773

RefSeq mRNA: 1 — MANE Select: NM_152250 NM_152250

CCDS: CCDS34832

Canonical transcript exons

ENST00000334773 — 3 exons

ExonStartEnd
ENSE0000167414678210047822132
ENSE0000179445378233827823423
ENSE0000217240178237697823880

Expression profiles

Bgee: expression breadth broad, 28 present calls, max score 37.20.

Top tissues by expression

124 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
colonic epitheliumUBERON:000039737.20gold quality
ventricular zoneUBERON:000305336.48gold quality
cortical plateUBERON:000534336.47gold quality
bone marrow cellCL:000209236.16gold quality
ganglionic eminenceUBERON:000402335.49gold quality
skeletal muscle tissueUBERON:000113433.38gold quality
muscle tissueUBERON:000238533.08silver quality
hindlimb stylopod muscleUBERON:000425232.15gold quality
bone marrowUBERON:000237131.74gold quality
stromal cell of endometriumCL:000225529.87gold quality
prefrontal cortexUBERON:000045129.04gold quality
duodenumUBERON:000211428.14gold quality
liverUBERON:000210728.04gold quality
lymph nodeUBERON:000002927.57gold quality
bloodUBERON:000017827.08gold quality
tonsilUBERON:000237227.05gold quality
leukocyteCL:000073826.55gold quality
islet of LangerhansUBERON:000000626.55gold quality
monocyteCL:000057626.45gold quality
vermiform appendixUBERON:000115426.42gold quality
gall bladderUBERON:000211025.98gold quality
olfactory segment of nasal mucosaUBERON:000538625.89gold quality
placentaUBERON:000198725.81gold quality
urinary bladderUBERON:000125525.72gold quality
cortex of kidneyUBERON:000122525.53gold quality
endometriumUBERON:000129524.65silver quality
primary visual cortexUBERON:000243624.61gold quality
superior frontal gyrusUBERON:000266124.08gold quality
kidneyUBERON:000211323.95gold quality
pancreasUBERON:000126423.89gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-HCAD-38no2600.27
E-ANND-3no0.07

Regulation

Is transcription factor: no

Literature-anchored findings (GeneRIF, showing 3)

  • The epididymis-specific expression pattern of the beta-defensin isoform BD-5 has been characterized. (PMID:12193721)
  • Defensin-beta 105 displays antimicrobial activity against S. aureus and E. coli, among other bacteria. (PMID:21861459)
  • The native disulfide array of human defensin 5 is a requirement for its activity against Staphylococcus aureus. (PMID:21861459)

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
mus_musculusDefb12ENSMUSG00000043787
mus_musculusDefb35ENSMUSG00000058052
rattus_norvegicusDefb105bENSRNOG00000083461
rattus_norvegicusDefb105aENSRNOG00000090398

Paralogs (1): DEFB105B (ENSG00000186599)

Protein

Protein identifiers

Beta-defensin 105Q8NG35 (reviewed: Q8NG35)

Alternative names: Beta-defensin 5, Defensin, beta 105

All UniProt accessions (2): Q8NG35, A0A0K0K1I4

UniProt curated annotations — full annotation on UniProt →

Function. Has antibacterial activity.

Subcellular location. Secreted.

Tissue specificity. Specifically expressed in testis.

Similarity. Belongs to the beta-defensin family.

RefSeq proteins (1): NP_689463* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR025933Beta_defensin_domDomain

Pfam: PF13841

UniProt features (5 total): disulfide bond 3, signal peptide 1, peptide 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8NG35-F172.220.11

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Disulfide bonds (3): 43–74, 53–67, 57–73

Function

Pathways and Gene Ontology

Reactome pathways

2 pathways

IDPathway
R-HSA-1461957Beta defensins
R-HSA-1461973Defensins

MSigDB gene sets: 11 (showing top): REACTOME_INNATE_IMMUNE_SYSTEM, GOBP_DEFENSE_RESPONSE_TO_OTHER_ORGANISM, GOBP_DEFENSE_RESPONSE_TO_BACTERIUM, ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN, GOBP_RESPONSE_TO_BACTERIUM, REACTOME_ANTIMICROBIAL_PEPTIDES, SCHERER_PBMC_YF_VAX_AGE_18_40YO_4_TO_7DY_UP, GOBP_BIOLOGICAL_PROCESS_INVOLVED_IN_INTERSPECIES_INTERACTION_BETWEEN_ORGANISMS, REACTOME_DEFENSINS, REACTOME_BETA_DEFENSINS, chr8p23

GO Biological Process (3): defense response to bacterium (GO:0042742), innate immune response (GO:0045087), defense response (GO:0006952)

GO Molecular Function (0):

GO Cellular Component (1): extracellular region (GO:0005576)

Reactome top-level categories

Rollup of top-2 pathways:

CategoryPathways
Defensins1
Antimicrobial peptides1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
defense response1
response to bacterium1
immune response1
defense response to symbiont1
response to stress1
cellular anatomical structure1

Protein interactions and networks

STRING

184 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
DEFB105ADEFB106AQ8N104928
DEFB105ADEFB104AQ8WTQ1914
DEFB105ADEFB107AQ8IZN7883
DEFB105ADEFB103AP81534880
DEFB105AA0A0G2JN59A0A0G2JN59832
DEFB105ADEFB108BQ8NET1815
DEFB105ADEFB1P60022811
DEFB105ADEFB4AO15263697
DEFB105APRR23D1E9PI22583
DEFB105ADEFB110Q30KQ9570
DEFB105ADEFB126Q9BYW3552
DEFB105ADEFA5Q01523546
DEFB105AUSP17L4A6NCW7518
DEFB105AFAM90A7A6NKC0515
DEFB105APRR23BQ6ZRT6509

IntAct

3 interactions, top by confidence:

ABTypeScore
DEFB105Apsi-mi:“MI:0915”(physical association)0.560
DEFB105Apsi-mi:“MI:0915”(physical association)0.000

BioGRID (2): DEFB105A (Two-hybrid), DEFB105B (Two-hybrid)

ESM2 similar proteins: A0A096LNP1, A4H206, A4H207, A4H208, A4H209, A4H212, A4H213, P0C8A5, P0C8B0, P0DP73, P0DP74, P59861, P82020, P82172, Q30KJ3, Q30KJ5, Q30KJ6, Q30KJ8, Q30KJ9, Q30KK8, Q30KL4, Q30KL6, Q30KM9, Q30KP5, Q30KP6, Q30KP8, Q30KQ1, Q30KQ6, Q30KQ7, Q30KQ9, Q32ZF3, Q32ZF7, Q32ZG3, Q32ZH4, Q32ZH5, Q32ZH6, Q32ZI1, Q32ZI2, Q4QY38, Q6QLQ7

Diamond homologs: A4H206, A4H207, A4H208, A4H209, Q30KQ1, Q32ZH6, Q32ZH9, Q5IAB6, Q8K4N3, Q8NG35, Q8R2I3, Q30KJ6, Q30KU3, Q30KQ6, Q32ZH8

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

8 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance4
Likely benign2
Benign2

Top pathogenic / likely-pathogenic (0)

SpliceAI

363 predictions. Top by Δscore:

VariantEffectΔscore
8:7823378:TTACC:Tdonor_loss0.9900
8:7823379:TACCT:Tdonor_loss0.9900
8:7823380:A:ATdonor_loss0.9900
8:7823765:TTACC:Tdonor_loss0.9900
8:7823766:TACC:Tdonor_loss0.9900
8:7823767:A:ACdonor_gain0.9900
8:7823767:A:ATdonor_loss0.9900
8:7823768:C:CCdonor_gain0.9900
8:7823768:C:CGdonor_loss0.9900
8:7823823:T:TAdonor_gain0.9900
8:7823421:ACCC:Aacceptor_loss0.9800
8:7823422:CC:Cacceptor_gain0.9800
8:7823423:CC:Cacceptor_gain0.9800
8:7823424:CTAA:Cacceptor_loss0.9800
8:7823425:T:Aacceptor_loss0.9800
8:7822202:C:CTacceptor_gain0.9700
8:7822205:C:CTacceptor_gain0.9700
8:7823377:CTTA:Cacceptor_loss0.9700
8:7823378:TTA:Tacceptor_loss0.9700
8:7823379:TACC:Tacceptor_loss0.9700
8:7823380:A:AGacceptor_loss0.9700
8:7823420:CACC:Cacceptor_gain0.9700
8:7823424:C:CCacceptor_gain0.9700
8:7823767:AC:Adonor_gain0.9700
8:7823768:CC:Cdonor_gain0.9700
8:7823768:CCT:Cdonor_gain0.9700
8:7822206:A:Tacceptor_gain0.9600
8:7823376:ACTT:Aacceptor_loss0.9600
8:7823380:A:ACdonor_gain0.9600
8:7823381:C:CCdonor_gain0.9600

AlphaMissense

509 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
8:7822087:C:GC53S0.941
8:7822088:A:TC53S0.941
8:7822108:C:GC46S0.916
8:7822109:A:TC46S0.916
8:7822088:A:GC53R0.912
8:7822076:A:GC57R0.899
8:7822075:C:GC57S0.897
8:7822076:A:TC57S0.897
8:7822045:C:GC67S0.895
8:7822046:A:TC67S0.895
8:7822027:C:GC73S0.894
8:7822028:A:TC73S0.894
8:7822108:C:TC46Y0.893
8:7822024:C:GC74S0.881
8:7822025:A:TC74S0.881
8:7822086:G:CC53W0.862
8:7822028:A:GC73R0.861
8:7822026:G:CC73W0.860
8:7822044:G:CC67W0.845
8:7822109:A:GC46R0.843
8:7822046:A:GC67R0.841
8:7822107:G:CC46W0.838
8:7822074:G:CC57W0.834
8:7822108:C:AC46F0.827
8:7822023:G:CC74W0.823
8:7822118:A:GC43R0.823
8:7822087:C:TC53Y0.820
8:7822025:A:GC74R0.817
8:7822087:C:AC53F0.810
8:7822117:C:GC43S0.806

dbSNP variants (sampled 300 via entrez): RS1000234208 (8:7823030 C>T), RS1010340219 (8:7821456 C>G,T), RS1020354130 (8:7822042 C>T), RS1024826176 (8:7824724 C>G,T), RS112399468 (8:7824719 CTT>C), RS113792280 (8:7822603 T>A), RS1156451028 (8:7823439 A>G), RS1156552300 (8:7824850 A>G), RS1157488093 (8:7821094 T>G), RS1157708231 (8:7823315 C>G,T), RS1157848324 (8:7821274 T>C), RS1158329291 (8:7821713 G>C), RS1158788226 (8:7825141 T>C), RS1159258551 (8:7821751 T>G), RS1159772138 (8:7821289 A>C)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

2 total (human), top 2 by PubMed support.

ChemicalActions (top 5)PubMed papers
CGP 52608affects binding, increases reaction1
Aflatoxin B1increases methylation1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.